VivaTech 2025: Practical Innovations for Clinical and Preventive Care
June 30, 2025 | 5 mins read
VivaTech 2025 in Paris highlighted a range of health technologies with clear clinical and preventive value. The event emphasized AI, robotics, and medical device innovation, reflecting how digital tools are increasingly integrated into healthcare delivery. Emerging companies presented solutions focused on improving diagnostic accuracy, lowering costs, and streamlining clinical workflows.
AI-Enhanced Diagnostic Tools
Several AI-powered diagnostic platforms stood out for their potential clinical impact. SkinMed (France), in collaboration with Anapix Medical, introduced a pharmacy-friendly tool for skin cancer screening. It combines imaging and machine learning to detect melanoma and other lesions early, speeding up referrals.
From Singapore, Evelab Insight showcased a dermatological analysis system measuring 42 facial dimensions using a database of 10 million images. While initially aimed at cosmetic dermatology, its AI platform could support remote patient monitoring and dermatologic assessment.
In mental health, Emobot (France) launched an AI tool that identifies depressive and bipolar symptoms via facial analysis. Targeted at elder care and outpatient settings, it offers a subtle way to track mood changes over time and assist triage.
Preventive Screening and Health Monitoring
Technologies supporting early detection outside traditional clinics were a clear focus. Bodyo (France) presented a self-service station that records blood pressure, ECG, blood glucose, and lipid profiles. Deployed in pharmacies, workplaces, or underserved areas, it targets risk factors early to reduce downstream costs.
Reveal AI (Canada), a finalist in the Tech for Change Awards, demonstrated an intraoperative visualization platform. It helps surgeons identify infiltrative cancer cells with submillimeter precision, aiming to improve surgical outcomes and reduce recurrence.
Strapplife introduced “Sticare,” a wearable sticker that discreetly reminds elderly patients to take medication, addressing a common challenge in geriatric pharmacotherapy.
Assistive Devices and Neurotechnology
Assistive technologies were also prominent. South Korea’s Mand.ro presented a robotic prosthetic hand controlled by sensors in rings or bracelets, removing the need for invasive interfaces. This innovation has clear benefits for upper-limb amputation rehabilitation.
Japan’s Ashirase unveiled a wearable navigation device for people with visual impairments. Attached to the shoe, it provides spatial guidance via vibrations, enhancing independent mobility.
Canada-based AAVAA displayed non-invasive neural interfaces that convert bioelectric signals into device commands. These could support individuals with severe motor impairments, offering intuitive, hands-free communication options.
Canada’s Strategic Role in Medical AI
As Country of the Year at VivaTech, Canada’s leadership in responsible AI deployment was evident. Montreal’s Mila institute continues to shape AI ethics and clinical standards globally. Cohere develops foundational language models with potential for clinical decision support and documentation automation.
Trusting Pixels focuses on detecting manipulated visual content, which can help combat health misinformation. BrainBox AI applies deep learning to optimize healthcare facility HVAC systems, supporting sustainability goals. Medeloop uses autonomous AI agents to accelerate medical research workflows, enabling smaller institutions to conduct studies more efficiently.
The innovations at VivaTech 2025 reflect a clear move toward scalable, preventive, and AI-assisted healthcare solutions. These range from early diagnosis and surgical assistance to medication adherence and accessibility. For healthcare professionals, they represent new tools to improve patient outcomes and potentially reduce costs. Clinical validation and ongoing evaluation will be key to integrating these advancements into everyday care.
Your membership also unlocks:
